MediWound Ltd. (MDWD)
NASDAQ: MDWD
· Real-Time Price · USD
18.11
-0.46 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
18.10
-0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT
MediWound Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.96M | 5.84M | 4.36M | 5.06M | 4.96M | 5.34M | 4.78M | 4.77M | 3.8M | 11.62M | 5.8M | 4.67M | 4.41M | 5.49M | 6.37M | 6.06M | 5.85M |
Cost of Revenue | 3.22M | 4.94M | 3.68M | 4.62M | 4.36M | 4.62M | 3.88M | 3.64M | 2.97M | 3.46M | 3.37M | 3.56M | 2.95M | 3.95M | 3.92M | 3.7M | 3.43M |
Gross Profit | 738K | 903K | 677K | 447K | 607K | 719K | 896K | 1.14M | 826K | 8.16M | 2.43M | 1.11M | 1.46M | 1.54M | 2.46M | 2.36M | 2.42M |
Operating Income | -5.22M | -6.1M | -5.08M | -4.48M | -3.73M | -3.89M | -3.02M | -4.01M | -4.36M | -9.44M | -3.51M | -3.37M | -3.28M | -3.52M | -2.88M | -2.9M | -1.92M |
Interest Income | 4.5M | 2.21M | n/a | 582K | n/a | 2.27M | 877K | 5.83M | 676K | 438K | 97K | 11K | 139K | n/a | n/a | 118K | 11K |
Pretax Income | -721K | -3.89M | -10.26M | -6.31M | -9.71M | -1.62M | -2.15M | 928K | -3.69M | -7.39M | -4.19M | -4.35M | -3.58M | -4.16M | -3.34M | -3.18M | -2.85M |
Net Income | -726K | -3.91M | -10.28M | -6.3M | -9.73M | -1.74M | -2.2M | 916K | -3.69M | -7.46M | -4.2M | -4.35M | -3.59M | -4.16M | -3.35M | -3.19M | -2.85M |
Selling & General & Admin | 3.07M | 3.77M | 3.23M | 3.03M | 2.87M | 2.56M | 2.61M | 3.12M | 3.09M | 2.96M | 3.06M | 2.29M | 2.34M | 2.6M | 2.44M | 2.6M | 2.1M |
Research & Development | 2.89M | 2.99M | 2.52M | 1.9M | 1.47M | 1.81M | 1.53M | 2.02M | 2.1M | 2.7M | 2.88M | 2.19M | 2.41M | 2.46M | 2.9M | 2.66M | 2.24M |
Other Expenses | 4K | 246K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 958K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.96M | 7M | 5.76M | 4.93M | 4.34M | 4.6M | 3.92M | 5.14M | 5.19M | 6.34M | 5.94M | 4.48M | 4.74M | 5.06M | 5.34M | 5.26M | 4.34M |
Interest Expense | n/a | n/a | 5.18M | 2.4M | 5.97M | n/a | n/a | 893K | n/a | 1.03M | 781K | 687K | 440K | 635K | 457K | 399K | 941K |
Selling & Marketing Expenses | 1.29M | -270K | 1.06M | 1.22M | 1.18M | 4.84M | n/a | 1.33M | 1.11M | 692K | n/a | 935K | 919K | 840K | 872K | 854K | 822K |
Cost & Expenses | 9.18M | 11.94M | 9.44M | 9.55M | 8.7M | 9.22M | 7.8M | 8.78M | 8.16M | 9.8M | 9.31M | 8.03M | 7.69M | 9.01M | 9.26M | 8.95M | 7.77M |
Income Tax Expense | 5K | 18K | 21K | -2K | 24K | 120K | 48K | 12K | 5K | 65K | 5K | 4K | 4K | 4K | 4K | 19K | n/a |
Shares Outstanding (Basic) | 10.37M | 10.79M | 10.51M | 9.28M | 9.23M | 9.22M | 9.22M | 9.21M | 8.39M | 6.33M | 4.78M | 4.73M | 4.11M | 3.89M | 3.89M | 3.89M | 3.89M |
Shares Outstanding (Diluted) | 10.8M | 10.79M | 10.51M | 9.28M | 9.23M | 9.22M | 9.22M | 9.21M | 8.39M | 6.33M | 4.78M | 4.73M | 4.11M | 3.89M | 3.89M | 3.89M | 3.89M |
EPS (Basic) | -0.07 | -0.36 | -0.98 | -0.68 | -1.05 | -0.19 | -0.24 | 0.10 | -0.44 | -1.18 | -0.88 | -0.92 | -0.87 | -1.05 | -0.84 | -0.84 | -0.7 |
EPS (Diluted) | -0.07 | -0.36 | -0.98 | -0.68 | -1.05 | -0.19 | -0.24 | 0.10 | -0.44 | -1.18 | -0.88 | -0.92 | -0.87 | -1.07 | -0.84 | -0.84 | -0.7 |
EBITDA | -4.87M | -15.71M | -4.72M | -4.13M | -3.37M | -1.28M | -2.69M | -3.69M | -4.06M | -8.77M | -3.17M | -3.35M | -2.96M | -3.25M | -2.55M | -2.46M | -1.65M |
EBIT | -5.22M | -16.11M | -5.08M | -4.48M | -3.73M | -1.62M | -3.02M | -4.01M | -4.36M | -9.05M | -3.41M | -3.67M | -3.28M | -3.52M | -2.88M | -2.78M | -1.92M |
Depreciation & Amortization | 358K | 397K | 361K | 357K | 368K | 346K | 339K | 315K | 303K | 283K | 338K | 329K | 321K | 276K | 335K | 319K | 273K |